No Clinically Significant CYP450 Interactions Between These Medications and Creatine
None of lamotrigine (Lamictal), aripiprazole (Abilify), finasteride, topical minoxidil, or creatine supplementation have meaningful cytochrome P450 interactions with each other. You can safely use creatine supplementation alongside this medication regimen without concern for metabolic drug interactions.
Individual Drug Metabolism Profiles
Finasteride does not interact with the cytochrome P450 system at all. The FDA label explicitly states "No drug interactions of clinical importance have been identified. Finasteride does not appear to affect the cytochrome P450-linked drug metabolizing enzyme system" 1. It has been tested with multiple medications without clinically meaningful interactions.
Lamotrigine is metabolized primarily through glucuronidation (forming a 2-N-glucuronide conjugate), not through CYP450 enzymes 2. While its clearance can be affected by enzyme inducers like carbamazepine or phenytoin, and inhibitors like valproate, neither finasteride, aripiprazole, minoxidil, nor creatine affect these pathways 3, 4.
Aripiprazole is metabolized by CYP3A4 and CYP2D6 5. However, none of your other medications are significant inhibitors or inducers of these enzymes. The research shows aripiprazole has no effect on lamotrigine pharmacokinetics 4, and finasteride doesn't interact with CYP450 systems 1.
Topical minoxidil has negligible systemic absorption—well below the 20 ng/mL threshold where any hemodynamic effects occur 6. Even oral minoxidil at antihypertensive doses (10-40 mg daily) doesn't have significant CYP450 interactions 7, 8. The low-dose topical formulation you're using has essentially no systemic drug interaction potential.
Creatine supplementation does not interact with cytochrome P450 enzymes. The recent systematic review found that creatine causes only a modest, transient increase in serum creatinine (0.07 µmol/L) due to metabolic turnover, not renal impairment, with no effect on glomerular filtration rate 9. This is a laboratory artifact, not a drug interaction.
Key Clinical Points
The slight creatinine elevation from creatine supplementation (if it occurs) is not a drug interaction—it's simply increased creatinine production from creatine metabolism 9
Aripiprazole and lamotrigine can be safely combined without dose adjustment 4
Finasteride's lack of CYP450 involvement makes it exceptionally safe from a drug interaction standpoint 1
Topical minoxidil absorption is too low to cause systemic interactions 6
No Dose Adjustments Required
Continue all medications at their prescribed doses. The combination is metabolically compatible. Monitor for the expected therapeutic and adverse effects of each individual medication, but drug-drug interactions through CYP450 pathways are not a concern with this regimen.